138 related articles for article (PubMed ID: 16818659)
1. GM2 expression in renal cell carcinoma: potential role in tumor-induced T-cell dysfunction.
Biswas K; Richmond A; Rayman P; Biswas S; Thornton M; Sa G; Das T; Zhang R; Chahlavi A; Tannenbaum CS; Novick A; Bukowski R; Finke JH
Cancer Res; 2006 Jul; 66(13):6816-25. PubMed ID: 16818659
[TBL] [Abstract][Full Text] [Related]
2. Gangliosides expressed by the renal cell carcinoma cell line SK-RC-45 are involved in tumor-induced apoptosis of T cells.
Kudo D; Rayman P; Horton C; Cathcart MK; Bukowski RM; Thornton M; Tannenbaum C; Finke JH
Cancer Res; 2003 Apr; 63(7):1676-83. PubMed ID: 12670922
[TBL] [Abstract][Full Text] [Related]
3. Tumor-induced dysfunction in interleukin-2 production and interleukin-2 receptor signaling: a mechanism of immune escape.
Rayman P; Uzzo RG; Kolenko V; Bloom T; Cathcart MK; Molto L; Novick AC; Bukowski RM; Hamilton T; Finke JH
Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S81-7. PubMed ID: 10685665
[TBL] [Abstract][Full Text] [Related]
4. GM1 and tumor necrosis factor-alpha, overexpressed in renal cell carcinoma, synergize to induce T-cell apoptosis.
Das T; Sa G; Hilston C; Kudo D; Rayman P; Biswas K; Molto L; Bukowski R; Rini B; Finke JH; Tannenbaum C
Cancer Res; 2008 Mar; 68(6):2014-23. PubMed ID: 18339884
[TBL] [Abstract][Full Text] [Related]
5. Tumor-induced sensitivity to apoptosis in T cells from patients with renal cell carcinoma: role of nuclear factor-kappaB suppression.
Finke JH; Rayman P; George R; Tannenbaum CS; Kolenko V; Uzzo R; Novick AC; Bukowski RM
Clin Cancer Res; 2001 Mar; 7(3 Suppl):940s-946s. PubMed ID: 11300495
[TBL] [Abstract][Full Text] [Related]
6. Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma.
Bukur J; Rebmann V; Grosse-Wilde H; Luboldt H; Ruebben H; Drexler I; Sutter G; Huber C; Seliger B
Cancer Res; 2003 Jul; 63(14):4107-11. PubMed ID: 12874014
[TBL] [Abstract][Full Text] [Related]
7. TNF-alpha induction of GM2 expression on renal cell carcinomas promotes T cell dysfunction.
Raval G; Biswas S; Rayman P; Biswas K; Sa G; Ghosh S; Thornton M; Hilston C; Das T; Bukowski R; Finke J; Tannenbaum CS
J Immunol; 2007 May; 178(10):6642-52. PubMed ID: 17475896
[TBL] [Abstract][Full Text] [Related]
8. Interferon-alpha (IFN-alpha)-conditioned DC preferentially stimulate type-1 and limit Treg-type in vitro T-cell responses from RCC patients.
Gigante M; Mandic M; Wesa AK; Cavalcanti E; Dambrosio M; Mancini V; Battaglia M; Gesualdo L; Storkus WJ; Ranieri E
J Immunother; 2008 Apr; 31(3):254-62. PubMed ID: 18317362
[TBL] [Abstract][Full Text] [Related]
9. Peptidome from renal cell carcinoma contains antigens recognized by CD4+ T cells and shared among tumors of different histology.
Tassi E; Facchinetti V; Seresini S; Borri A; Dell'antonio G; Garavaglia C; Casorati G; Protti MP
Clin Cancer Res; 2006 Aug; 12(16):4949-57. PubMed ID: 16914584
[TBL] [Abstract][Full Text] [Related]
10. Structure, expression and function of HLA-G in renal cell carcinoma.
Seliger B; Schlaf G
Semin Cancer Biol; 2007 Dec; 17(6):444-50. PubMed ID: 17707652
[TBL] [Abstract][Full Text] [Related]
11. Glioblastomas induce T-lymphocyte death by two distinct pathways involving gangliosides and CD70.
Chahlavi A; Rayman P; Richmond AL; Biswas K; Zhang R; Vogelbaum M; Tannenbaum C; Barnett G; Finke JH
Cancer Res; 2005 Jun; 65(12):5428-38. PubMed ID: 15958592
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the expression of HLA class I, proinflammatory cytokines and chemokines in primary tumors from patients with localized and metastatic renal cell carcinoma.
Romero JM; Aptsiauri N; Vazquez F; Cozar JM; Canton J; Cabrera T; Tallada M; Garrido F; Ruiz-Cabello F
Tissue Antigens; 2006 Oct; 68(4):303-10. PubMed ID: 17026465
[TBL] [Abstract][Full Text] [Related]
13. Expression and regulation of non-classical HLA-G in renal cell carcinoma.
Dunker K; Schlaf G; Bukur J; Altermann WW; Handke D; Seliger B
Tissue Antigens; 2008 Aug; 72(2):137-48. PubMed ID: 18721274
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a proapoptotic antiganglioside GM2 monoclonal antibody and evaluation of its therapeutic effect on melanoma and small cell lung carcinoma xenografts.
Retter MW; Johnson JC; Peckham DW; Bannink JE; Bangur CS; Dresser K; Cai F; Foy TM; Fanger NA; Fanger GR; Woda B; Rock KL
Cancer Res; 2005 Jul; 65(14):6425-34. PubMed ID: 16024647
[TBL] [Abstract][Full Text] [Related]
15. Elevated levels of select gangliosides in T cells from renal cell carcinoma patients is associated with T cell dysfunction.
Biswas S; Biswas K; Richmond A; Ko J; Ghosh S; Simmons M; Rayman P; Rini B; Gill I; Tannenbaum CS; Finke JH
J Immunol; 2009 Oct; 183(8):5050-8. PubMed ID: 19801523
[TBL] [Abstract][Full Text] [Related]
16. Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.
Kausche S; Wehler T; Schnürer E; Lennerz V; Brenner W; Melchior S; Gröne M; Nonn M; Strand S; Meyer R; Ranieri E; Huber C; Falk CS; Herr W
Cancer Res; 2006 Dec; 66(23):11447-54. PubMed ID: 17145892
[TBL] [Abstract][Full Text] [Related]
17. PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma.
Thompson RH; Dong H; Lohse CM; Leibovich BC; Blute ML; Cheville JC; Kwon ED
Clin Cancer Res; 2007 Mar; 13(6):1757-61. PubMed ID: 17363529
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of motility and invasiveness of renal cell carcinoma induced by short interfering RNA transfection of beta 1,4GalNAc transferase.
Aoki H; Satoh M; Mitsuzuka K; Ito A; Saito S; Funato T; Endoh M; Takahashi T; Arai Y
FEBS Lett; 2004 Jun; 567(2-3):203-8. PubMed ID: 15178323
[TBL] [Abstract][Full Text] [Related]
19. Chemokine receptors expression and migration potential of tumor-infiltrating and peripheral-expanded Vgamma9Vdelta2 T cells from renal cell carcinoma patients.
Viey E; Lucas C; Romagne F; Escudier B; Chouaib S; Caignard A
J Immunother; 2008 Apr; 31(3):313-23. PubMed ID: 18317356
[TBL] [Abstract][Full Text] [Related]
20. Ganglioside DSGb5, preferred ligand for Siglec-7, inhibits NK cell cytotoxicity against renal cell carcinoma cells.
Kawasaki Y; Ito A; Withers DA; Taima T; Kakoi N; Saito S; Arai Y
Glycobiology; 2010 Nov; 20(11):1373-9. PubMed ID: 20663960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
